Metformin: all 1,377 studies that test it
Page 13 of 14. Open to participants first (169), then studies with results posted, then the rest; newest registration first within each.
- ADIponectin and Asymmetric Dimethylarginine (ADMA) Level in Type-2 Diabetes Patients After 12 Weeks of Treatment With GlimepiRide And Metformin Fixed Dose CombinationCompletedNCT01204580Phase 4
- Efficacy and Safety of Combination Therapy of Vildagliptin/Metformin in Patients in Type 2 Diabetes Mellitus (T2DM)CompletedNCT01196546Phase 4
- Metformin to Prevent Metabolic Complications in Glucocorticoid ExcessCompletedNCT01187849Phase 4
- Early Intervention for Gestational DiabetesWithdrawnNCT01171456Not applicable
- Combination Chemotherapy With or Without Metformin Hydrochloride in Treating Patients With Metastatic Pancreatic CancerTerminatedNCT01167738Phase 2
- Bioequivalence Study of Metformin Hydrochloride Tablets 1000 mg Tablets of Dr. Reddy's Laboratories Limited Under Fed ConditionCompletedNCT01160068Phase 1
- Bioequivalence Study of Metformin Hydrochloride Tablets 1000 mg Tablets of Dr. Reddy's Laboratories Limited Under Fasting ConditionCompletedNCT01160042Phase 1
- Study to Assess the Effect of Food on Combination Dapagliflozin/Metformin Tablet in Healthy VolunteersCompletedNCT01156246Phase 1
- Study to Assess Safety and Pharmacokinetics of Double-Blind S-707106 Alone and in Combination With Open-Label Metformin in Patients With Type 2 Diabetes MellitusCompletedNCT01154348Phase 1
- Initiation and Titration of AmarylCompletedNCT01144728Phase 4
- Treatment of Latent Autoimmune Diabetes of the AdultCompletedNCT01140438Not applicable
- Metformin and Folate in Pregnant Polycystic Ovary Syndrome(PCOS) WomenCompletedNCT01115140Phase 4
- Calcium, Vitamin D and Metformin to Treat Insulin Resistance in Obese African American Adolescent FemalesWithdrawnNCT01107808Not applicable
- The Effects of Hypolipemic and Antidiabetic Treatment on CytokinesStatus unknownNCT01101204Not applicable
- Bioequivalence Study of Metformin Hydrochloride Extended Release 750 mg Tablets Versus Glucophage XR® 750 mg Tablet in Healthy Volunteers Under Fed Conditions.CompletedNCT01089205Phase 1
- Bioequivalence Study of Metformin Hydrochloride Extended Release 750 mg Tablets Versus Glucophage XR® 750 mg Tablet in Healthy Volunteers Under Fasting Conditions.CompletedNCT01089192Phase 1
- Bioequivalence Study of Metformin Hydrochloride Extended Release 500 mg Tablet Versus Glucophage XR® 500 mg Tablet in Healthy Volunteers Under Fed ConditionsCompletedNCT01089179Phase 1
- Study to Compare the Bioavailability of Extended Release Metformin HCl Tablet Versus Glucophage XR® Tablets in Healthy Human Volunteers Under Fasting ConditionCompletedNCT01089166Phase 1
- Lapatinib With Sirolimus or MetforminCompletedNCT01087983Phase 1
- Metformin Versus Insulin in the Treatment of Gestational Diabetes MellitusCompletedNCT01087866Phase 2/3
- Effect of Treatment With Insulin Sensitizer on Arterial Properties, Metabolic Parameters and Liver Function in Patients With Nonalcoholic Fatty Liver DiseaseCompletedNCT01084486Phase 1/2
- Metformin in Preventing Androgen Deprivation Therapy Induced Insulin Resistance and Metabolic SyndromeCompletedNCT01077479Phase 2
- A Study Comparing the Amount of Metformin and After Taking a Combination Tablet vs. Separate TabletsCompletedNCT01055691Phase 1
- Myo-inositol Versus Metformin Administration in Post-menopausal Women With Metabolic SyndromeStatus unknownNCT01046500Phase 2
- Metformin Treatment Before in Vitro Fertilization (IVF) in Women With Ultrasound Evidence of Polycystic OvariesCompletedNCT01046032Not applicable
- Myocardial Perfusion in Type 2 DiabetesCompletedNCT01043965Phase 1/2
- Effects of Lipemia and Metformin on Endothelial FunctionCompletedNCT01037660Early Phase 1
- Can Insulin Glargine Improve Myocardial Function in Patients With T2D and Coronary Artery Disease (CAD)Status unknownNCT01035528Phase 4
- The Effects of Oral Hypoglycemic Agents on Chronic Hepatitis C Patients Receiving Peg-Intron Plus RibavirinStatus unknownNCT01025765Phase 4
- Drug Interaction Between CKD-501 and MetforminCompletedNCT01005160Phase 1
- Bioavailability Study of Fixed Dose Combination (FDC) Formulations of Dapagliflozin and Metformin XR Versus Individual Component Coadministered to Healthy Subjects in a Fasted StateCompletedNCT01002807Phase 1
- Double Blind Placebo Study of JARDIANCE® (Empagliflozin) in Prehypertensives Type II DiabeticsStatus unknownNCT01001962Phase 4
- The Effects of Metformin on Pregnancy and Miscarriage Rates in Polycystic Ovary Syndrome (PCOS)CompletedNCT00994812Phase 3
- Effects of Metformin and Oral Hormonal Contraceptive in Adolescents With Polycystic Ovary SyndromeStatus unknownNCT00988078Not applicable
- A Study of the Effects of Sitagliptin (MK0431) and Metformin on Incretin Hormone Concentrations (0431-050)(COMPLETED)CompletedNCT00975052Phase 1
- Predictive Parameters for Efficacy of Sitagliptin and Metformin CombinationCompletedNCT00969566Phase 4
- Phenotypic and Genetic Correlates of Diabetes (Non-Type 1) in Young Non-Obese Asian Indians in North India and A Study to Evaluate the Efficacy of Sitagliptin (DPP-4 Inhibitor) in a Sub-group of the Study PopulationCompletedNCT00964184Phase 4
- Metformin and Folate Supplementation in Polycystic Ovary Syndrome (PCOS) PatientsCompletedNCT00953355Phase 4
- PED/PEA-15 Protein, PCOS, Obesity, Insulin Sensitivity Indexes, Metformin, Oral ContraceptivesCompletedNCT00948402Phase 3
- Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Glucophage®, Bristol-Myers Squibb Company) in Fed, Healthy, Adult SubjectsCompletedNCT00944346Phase 1
- Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Glucophage®, Bristol-Myers Squibb Company) in Fasted, Healthy, Adult SubjectsCompletedNCT00944177Phase 1
- Tolerability and Pharmacokinetics of Metformin and Metformin Extended Release (ER)CompletedNCT00941239Phase 1
- Comparative Study of HOE490 O (Glimepiride and Metformin) Compared With Placebo on Top of GlimepirideCompletedNCT00924573Phase 3
- Efficacy and Safety of Adjuvant Metformin for Operable Breast Cancer PatientsCompletedNCT00909506Phase 2
- Clinical and Biologic Effects of Metformin in Early Stage Breast CancerCompletedNCT00897884Not applicable
- Hypothalamic Obesity Following Craniopharyngioma Surgery: A Pilot Trial of Combined Metformin and Diazoxide TherapyCompletedNCT00892073Phase 2
- Effect of Exercise or Metformin on Nocturnal Blood Pressure and Other Risk Factors for CVD Among Obese AdolescentsTerminatedNCT00889876Not applicable
- Metformin and Gestational Diabetes in High-risk Patients: a RCTsStatus unknownNCT00883259Phase 4
- To Demonstrate the Relative Bioavailability of Metformin HCL 500 mg Extended Release (XR) Tablets Under Fasting ConditionsCompletedNCT00882882Phase 1
- A Study of Pre-operative Metformin in Prostate CancerTerminatedNCT00881725Phase 2
- A Relative Bioavailability Study of Metformin HCl 750 mg ER Tablets Under Non-fasting ConditionsCompletedNCT00865852Phase 1
- A Relative Bioavailability Study of Metformin HCl 500 mg ER Tablets Under Fasting ConditionsCompletedNCT00865839Phase 1
- A Relative Bioavailability Study of Metformin HCl 500 mg ER Tablets Under Fasting ConditionsCompletedNCT00865748Phase 1
- A Relative Bioavailability Study of Metformin HCl 750 mg ER Tablets Under Fasting ConditionsCompletedNCT00865072Phase 1
- A Relative Bioavailability Study of Metformin HCl 500 mg ER Tablets Under Non-fasting ConditionsCompletedNCT00864669Phase 1
- Insulin Glargine First Line vs Metformin in Type 2 Diabetic SubjectsCompletedNCT00857870Phase 4
- Metformin for Weight Control in Adolescents Taking Atypical AntipsychoticsStatus unknownNCT00845936Phase 4
- Safety of Hormonal Contraceptives Therapies in Polycystic Ovary Syndrome (PCOS) WomenCompletedNCT00842140Not applicable
- Comparison of the Effects of Repaglinide and Metformin on Glucose ExcursionsStatus unknownNCT00832481Not applicable
- Investigation Of How PD 0332334 And Metformin Are Eliminated From The Body When They Are Administered At The Same TimeTerminatedNCT00809536Phase 1
- PCOSMIC Trial - PolyCystic Ovary Syndrome, Metformin for Infertility With ClomipheneCompletedNCT00795808Phase 4
- Insulin Glargine Combination Therapies in Type II DiabeticsCompletedNCT00783744Phase 3
- Bioequivalence Study of Metformin Hydrochloride 1000mg Tablets Under Fed ConditionsCompletedNCT00778466Not applicable
- Bioequivalence Study of Metformin Hydrochloride 1000mg Tablets Under Fasting ConditionsCompletedNCT00778427Not applicable
- A Comparitive Bioavailability Study of Metformin Hydrochloride Liquid 500mg/ 5 mL Under Fasting Conditions and After Low and High Fat MealCompletedNCT00778349Not applicable
- Efficacy and Safety Study of Pioglitazone Combined With Metformin on Metabolic Syndrome in Subjects With Type 2 DiabetesCompletedNCT00772174Phase 3
- Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus.CompletedNCT00770835Phase 4
- Efficacy of Pioglitazone and Metformin on Cardiovascular Risk in Subjects With Insulin-Treated Type 2 Diabetes Mellitus.CompletedNCT00770445Phase 4
- Safety and Efficacy of TAK-559 in Combination With Metformin in Patients With Type 2 Diabetes Mellitus.TerminatedNCT00762957Phase 3
- Study of Rimonabant/Metformin Combinations to Investigate Diabetes (Blood Sugar) Control in Patients With Type 2 DiabetesWithdrawnNCT00754689Phase 3
- Efficacy of Pioglitazone and Fortamet Combination Therapy in Subjects With Type 2 DiabetesCompletedNCT00754403Phase 4
- A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.CompletedNCT00744367Phase 3
- Efficacy and Safety of Fixed Combination Therapy of Vildagliptin and Metformin (25/1000 mg Bid) in Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy (HbA1c 7.0-9.5%)CompletedNCT00728351Phase 3
- Carotid Atherosclerosis: MEtformin for Insulin ResistAnce StudyCompletedNCT00723307Phase 4
- Metformin in Children With Motor DeficitCompletedNCT00720161Not applicable
- Optimal Oral Hypoglycaemic Agents (OHA) for Combination With Insulin Glargine (Sulfonylurea vs. Metformin)CompletedNCT00708578Phase 4
- A Randomized, Double-Blind Trial Comparing the Efficacy and Safety of Fenofibrate, Metformin, Their Combination and Placebo in Patients With Metabolic Syndrome.CompletedNCT00703755Phase 2
- Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH)Status unknownNCT00699036Phase 2
- Safety and Efficacy of INCB013739 Plus Metformin Compared to Metformin Alone on Glycemic Control in Type 2 DiabeticsCompletedNCT00698230Phase 2
- Cortisol Regulation in Polycystic Ovary Syndrome (PCOS)CompletedNCT00694759Not applicable
- Quantification of the Dipeptidyl Peptidase (DPP)-4 Inhibition-mediated Enhancement of the Activity of the Entero-insular AxisCompletedNCT00683735Phase 2/3
- Metformin in Gestational Diabetes MellitusCompletedNCT00681460Not applicable
- Metformin and Lifestyle Intervention in Women With Polycystic Ovary SyndromeCompletedNCT00679679Phase 4
- Risk Reduction in Coronary Heart DiseaseCompletedNCT00679237Not applicable
- Metabolic Effect of Metformin in Obese Insulin Resistant Adolescents With Normal Glucose ToleranceCompletedNCT00667498Phase 4
- Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or LymphomaCompletedNCT00659568Phase 1
- The Copenhagen Insulin and Metformin Therapy TrialCompletedNCT00657943Phase 4
- Fasting Study of Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR Tablets 500 mgCompletedNCT00650312Phase 1
- Fasting BE Study of Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR Tablets 500 mgCompletedNCT00650234Phase 1
- Food BE Study Metformin Hydrochloride ER Tablets 500 mg and Glucophage XR 500 mgCompletedNCT00649948Phase 1
- Food Study Metformin Hydrochloride ER Tablets 750 mg and Glucophage XR 750 mgCompletedNCT00649350Phase 1
- Fasting Study of Metformin Hydrochloride ER Tablets 750 mg and Glucophage® XR Tablets 750 mgCompletedNCT00648518Phase 1
- Food Study Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR 500 mgCompletedNCT00648492Phase 1
- Incretin Secretion in Women With Polycystic Ovary Syndrome (PCOS)TerminatedNCT00647023Not applicable
- Diagnosis and Therapy of Vulnerable Atherosclerotic PlaqueCompletedNCT00636766Not applicable
- DZX Mediated Insulin Suppression in Obese MenCompletedNCT00631033Phase 2
- Efficacy and Safety of Biphasic Insulin Aspart 30 With Metformin in Type 2 DiabetesCompletedNCT00624364Phase 4
- Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 DiabetesCompletedNCT00619697Phase 4
- Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD TherapyCompletedNCT00598793Phase 3
- Efficacy and Safety of Metformin Plus Biphasic Insulin Aspart 30 in Type 2 DiabetesCompletedNCT00592969Phase 4